Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05771597 · ClinicalTrials.gov registry record · NA
Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence
A NA study of Urinary Incontinence and Fecal Incontinence, sponsored by Augusta University.
- Recruiting
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT05771597 is a NA study of Urinary Incontinence and Fecal Incontinence that is actively recruiting participants, run by Augusta University. The registered enrollment target is 72 participants, below the 261-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05771597, a NA study of Urinary Incontinence and Fecal Incontinence, is actively recruiting participants, sponsored by Augusta University.
- RECRUITING
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
Biofeedback therapy is an effective treatment for the management of patients with dyssynergic defecation and constipation, urinary incontinence (UI), and fecal incontinence (FI). It is labor-intensive, costly, requires multiple office or hospital visits, is not easily available to the vast majority of patients in the community, and is not covered by many insurance companies. The purpose of this study is to 1. Evaluate home biofeedback therapy for patients with either constipation and dyssynergic defecation or urinary leakage or stool leakage by assessing the efficacy and safety of a wireless anorectal biofeedback device, and a cellphone app-based and voice guided home biofeedback training system 2. To compare the efficacy and safety of home biofeedback therapy system with the standard of care, office biofeedback therapy 3. To assess the cost-effectiveness of home biofeedback therapy.
Conditions Studied
Interventions
- OTHER Home Biofeedback therapy
- OTHER Office biofeedback therapy
Study Locations (1)
Georgia
- Augusta University - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2023-03-27 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05771597
The ClinicalTrials.gov registry entry for NCT05771597 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (72% lower). The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Urinary Incontinence appearing as the primary indexed condition, and to 2 interventions - of which Home Biofeedback therapy is the first listed.
NCT05771597 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT05771597 about?
NCT05771597 is a clinical study titled "Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence". Biofeedback therapy is an effective treatment for the management of patients with dyssynergic defecation and constipation, urinary incontinence (UI), and fecal incontinence (FI). It is labor-intensive, costly, requires multiple office or hospital visits, is not easily available to the vast majority ...
What is the current status of trial NCT05771597?
This trial is currently recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2023-03-27. Estimated completion is 2026-12-31.
What conditions does trial NCT05771597 study?
This clinical trial studies the following conditions: Urinary Incontinence, Fecal Incontinence, Dyssynergic Defecation.
What interventions are being tested in trial NCT05771597?
The interventions under investigation include: Home Biofeedback therapy (OTHER), Office biofeedback therapy (OTHER).
Who is sponsoring clinical trial NCT05771597?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05771597 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
RECRUITING · NA
-
Improving Overactive Bladder Treatment Access and Adherence
RECRUITING · NA
-
Training for Urinary Leakage Improvement After Pregnancy
RECRUITING · NA
-
BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.